John M. Mariadason

12.0k total citations · 1 hit paper
139 papers, 8.3k citations indexed

About

John M. Mariadason is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, John M. Mariadason has authored 139 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 74 papers in Oncology and 39 papers in Pathology and Forensic Medicine. Recurrent topics in John M. Mariadason's work include Colorectal Cancer Treatments and Studies (33 papers), Genetic factors in colorectal cancer (31 papers) and Epigenetics and DNA Methylation (14 papers). John M. Mariadason is often cited by papers focused on Colorectal Cancer Treatments and Studies (33 papers), Genetic factors in colorectal cancer (31 papers) and Epigenetics and DNA Methylation (14 papers). John M. Mariadason collaborates with scholars based in Australia, United States and Spain. John M. Mariadason's co-authors include Leonard H. Augenlicht, Diego Arango, Georgia Corner, Andrew J. Wilson, Anna Velcich, Peter G. Gibson, Do-Sun Byun, Oliver M. Sieber, David H. Barkla and Wancai Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

John M. Mariadason

138 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FunRich: An open access standalone functional enrichment and interaction network analysis tool

2015 980 citations Dmitri Mouradov, Oliver M. Sieber et al. profile →

Peers

Countries citing papers authored by John M. Mariadason

Since Specialization

Citations

This map shows the geographic impact of John M. Mariadason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Mariadason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Mariadason more than expected).

Fields of papers citing papers by John M. Mariadason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Mariadason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Mariadason. The network helps show where John M. Mariadason may publish in the future.

Co-authorship network of co-authors of John M. Mariadason

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Mariadason. A scholar is included among the top collaborators of John M. Mariadason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Mariadason. John M. Mariadason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK 2021 ·Molecular Cancer Therapeutics ·(unknown), Ian Y. Luk, Laura J. Jenkins, Andrew Martin, David S. Williams, (unknown), Fiona Chionh, Michael Büchert, Katrin Marie Sjoquist, Alex Boussioutas, Sarah A. Hayes, Matthias Ernst, Andrew Weickhardt, Nick Pavlakis, Niall C. Tebbutt, John M. Mariadason	14
2	EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc -initiated colonic tumorigenesis 2021 ·Development ·(unknown), (unknown), Ian Y. Luk, Laura J. Jenkins, Frank Köentgen, David S. Williams, Charbel Darido, Fiona H. Tan, Holly Anderton, Michaël Chopin, (unknown), Moritz F. Eissmann, Michael Büchert, Dmitri Mouradov, Oliver M. Sieber, Matthias Ernst, Amardeep S. Dhillon, John M. Mariadason	11
3	BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival 2019 ·Cell Death and Disease ·Erinna F. Lee, Tiffany J. Harris, Sharon Tran, Marco Evangelista, Surein Arulananda, Thomas John, (unknown), (unknown), Haoran Zhu, Gency Gunasingh, David Segal, Andreas Behren, Jonathan Cebon, Alexander Dobrovic, John M. Mariadason, Andreas Strasser, Leona Rohrbeck, Nikolas K. Haass, Marco J. Herold, W. Douglas Fairlie	142
4	Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner 2018 ·Cancer Immunology Research ·Moritz F. Eissmann, Christine D. Dijkstra, Merridee A. Wouters, (unknown), Dmitri Mouradov, Paul M. Nguyen, Mercedes Dávalos-Salas, Tracy L. Putoczki, Oliver M. Sieber, John M. Mariadason, Matthias Ernst, Frédérick Masson	34
5	ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types 2017 ·Clinical Cancer Research ·Anderly C. Chüeh, Janson W.T. Tse, Michael Dickinson, (unknown), Laura J. Jenkins, Lars Tögel, (unknown), Ian Y. Luk, Mercedes Dávalos-Salas, (unknown), Matthew R. Thompson, Bryan Williams, Guillaume Lessène, Erinna F. Lee, W. Douglas Fairlie, Amardeep S. Dhillon, John M. Mariadason	44
6	Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells 2016 ·Molecular Cancer Therapeutics ·Lars Tögel, (unknown), Anderly C. Chüeh, Aparna Jayachandran, Hoanh Tran, Toby J. Phesse, Rui Wu, Oliver M. Sieber, Diego Arango, Amardeep S. Dhillon, Mark A. Dawson, Beatriz Díez-Dacal, Timothy C. Gahman, P. Filippakopoulos, Andrew K. Shiau, John M. Mariadason	74
7	Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment 2015 ·Clinical Cancer Research ·Sarah Bazzocco, Higinio Dopeso, Fernando Cartón‐García, Irati Macaya, Elena Andretta, Fiona Chionh, Paulo Rodrigues, (unknown), Hafid Alazzouzi, (unknown), Álex Sánchez‐Pla, Simó Schwartz, Josipa Bilić, John M. Mariadason, Diego Arango	30
8	Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer 2014 ·Cancer Research ·Dmitri Mouradov, Clare Sloggett, Robert N. Jorissen, Christopher G. Love, Shan Li, Antony W. Burgess, Diego Arango, Robert L. Strausberg, Daniel D. Buchanan, Samuel Wormald, Liam O’Connor, Jennifer L. Wilding, David Bicknell, Ian Tomlinson, Walter F. Bodmer, John M. Mariadason, Oliver M. Sieber	287
9	Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008 2013 ·Clinical Cancer Research ·Ingrid J.G. Burvenich, (unknown), Glenn A. Cartwright, Graeme O’Keefe, (unknown), Diana Cao, Sylvia Gong, Anderly C. Chüeh, John M. Mariadason, Martin W. Brechbiel, Robert A. Beckman, Kôsaku Fujiwara, Reinhard von Roemeling, Andrew M. Scott	13
10	Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents 2012 ·Clinical Cancer Research ·Muling Mao, Feng Tian, John M. Mariadason, Chun C. Tsao, Robert Lemos, Farshid Dayyani, Y.N. Vashisht Gopal, Zhi-Qin Jiang, Ignacio I. Wistuba, Xi Tang, William G. Bornman, Gideon Bollag, Gordon B. Mills, Garth Powis, Jayesh Desai, Gary E. Gallick, Michael A. Davies, Scott Kopetz	235
11	Villin Expression Is Frequently Lost in Poorly Differentiated Colon Cancer 2012 ·American Journal Of Pathology ·Diego Arango, Sheren Al-Obaidi, David S. Williams, Higinio Dopeso, Rocco Mazzolini, Georgia Corner, Do‐Sun Byun, Azadeh A. Carr, Carmel Murone, Lars Tögel, Nikolajs Zeps, Lauri A. Aaltonen, Barry Iacopetta, John M. Mariadason	26
12	Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction 2010 ·Cancer Research ·Andrew J. Wilson, Anderly C. Chüeh, Lars Tögel, Georgia Corner, Naseem Ahmed, Sanjay Goel, Do-Sun Byun, Shannon Nasser, Michele Houston, Minaxi Jhawer, Helena J.M. Smartt, Lucas B. Murray, Courtney Nicholas, Barbara G. Heerdt, Diego Arango, Leonard H. Augenlicht, John M. Mariadason	96
13	Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment 2010 ·Clinical Cancer Research ·Higinio Dopeso, Silvia Mateo‐Lozano, Élena Elez, Stefania Landolfi, (unknown), Javier Hernández‐Losa, Rocco Mazzolini, Paulo Rodrigues, Sarah Bazzocco, (unknown), Eloy Espín, Manel Armengol, Andrew J. Wilson, John M. Mariadason, Santiago Ramón y Cajal, Josep Tabernero, Simó Schwartz, Diego Arango	32
14	Altered Dynamics of Intestinal Cell Maturation in Apc1638N/+ Mice 2010 ·Cancer Research ·Donghai Wang, Rossanna C. Pezo, Georgia Corner, Cristina Sison, Martin Lesser, Shailesh M. Shenoy, John M. Mariadason, Robert H. Singer, Leonard H. Augenlicht	10
15	Prediction and Testing of Biological Networks Underlying Intestinal Cancer 2010 ·PLoS ONE ·Vishal Patel, Gürkan Bebek, John M. Mariadason, Donghai Wang, Leonard H. Augenlicht, Mark R. Chance	12
16	The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis 2009 ·Cancer Research ·Higinio Dopeso, Silvia Mateo‐Lozano, Rocco Mazzolini, Paulo Rodrigues, Laura Lagares‐Tena, Julián Cerón, (unknown), (unknown), Stefania Landolfi, Javier Hernández‐Losa, Julio Castaño, Andrew J. Wilson, Santiago Ramón y Cajal, John M. Mariadason, Simó Schwartz, Diego Arango	50
17	An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression 2009 ·Cancer Research ·Ziqiang Yuan, Joongho Shin, Andrew J. Wilson, Sanjay Goel, Yi‐He Ling, Naseem Ahmed, Higinio Dopeso, Minaxi Jhawer, Shannon Nasser, Cristina Montagna, Kenneth Fordyce, Leonard H. Augenlicht, Lauri A. Aaltonen, Diego Arango, Thomas K. Weber, John M. Mariadason	32
18	PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab 2008 ·Cancer Research ·Minaxi Jhawer, Sanjay Goel, Andrew J. Wilson, Cristina Montagna, Yi‐He Ling, Do-Sun Byun, Shannon Nasser, Diego Arango, Joongho Shin, Lidija Klampfer, Leonard H. Augenlicht, Roman Perez Soler, John M. Mariadason	370
19	EPHB4 and Survival of Colorectal Cancer Patients 2006 ·Cancer Research ·Verónica Dávalos, Higinio Dopeso, Julio Castaño, Andrew J. Wilson, F Vilardell, Jordi Romero‐Giménez, Eloy Espín, Manel Armengol, Gabriel Capellá, John M. Mariadason, Lauri A. Aaltonen, Simó Schwartz, Diego Arango	66
20	Mechanisms of Inactivation of the Receptor Tyrosine Kinase EPHB2 in Colorectal Tumors 2005 ·Cancer Research ·Hafid Alazzouzi, Verónica Dávalos, Antti Kokko, Enric Domingo, Stefan M. Woerner, Andrew J. Wilson, (unknown), Päivi Laiho, Eloy Espín, Manel Armengol, Kohzoh Imai, Hiroyuki Yamamoto, John M. Mariadason, Johannes Gebert, Lauri A. Aaltonen, Simó Schwartz, Diego Arango	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact